In the last 12 months, insiders at T2 Biosystems, Inc. ($TTOO) filed 49 transactions with the SEC: 0 open-market purchases totaling $0 and 1 sales totaling $133. Net insider sentiment: net selling.
T2 Biosystems, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Elsbree David B (Not found) — 2 transactions totaling $133
- Gibbs Michael Terrence (General Counsel) — 6 transactions totaling $0
- Adams Laura Lee (Not found) — 1 transaction totaling $0
- Sprague John M (CFO) — 2 transactions totaling $0
- Saunders Ninfa (Not found) — 1 transaction totaling $0
View all SEC Filings for T2 Biosystems, Inc. (TTOO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 4, 2024 | LIEBMAN SEYMOUR | Not found | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 5,512,332 | 9999.99% | 0.45% |
| Nov. 4, 2024 | Giffin Brett A. | Chief Commercial Officer | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 5,512,332 | 9999.99% | 3.27% |
| Nov. 4, 2024 | Giffin Brett A. | Chief Commercial Officer | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 5,512,332 | 9999.99% | 3.27% |
| Nov. 4, 2024 | Adams Laura Lee | Not found | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 5,512,332 | 9999.99% | 0.45% |
| Nov. 4, 2024 | CUMMING JOHN W | Not found | A | Restricted Stock Units | 35000 | $0.00 | 35,000.0000 | 5,512,332 | 9999.99% | 0.63% |
| Nov. 4, 2024 | Gibbs Michael Terrence | General Counsel | A | Restricted Stock Units | 190000 | $0.00 | 190,000.0000 | 5,512,332 | 9999.99% | 3.45% |
| Nov. 4, 2024 | Gibbs Michael Terrence | General Counsel | A | Restricted Stock Units | 190000 | $0.00 | 190,000.0000 | 5,512,332 | 9999.99% | 3.45% |
| Nov. 4, 2024 | Saunders Ninfa | Not found | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 5,512,332 | 9999.99% | 0.45% |
| Nov. 4, 2024 | Toft Robin | Not found | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 5,512,332 | 9999.99% | 0.45% |
| Nov. 4, 2024 | Sperzel John J III | See Remarks | A | Restricted Stock Units | 490000 | $0.00 | 490,000.0000 | 5,512,332 | 9999.99% | 8.89% |
| Nov. 4, 2024 | Sperzel John J III | See Remarks | A | Restricted Stock Units | 490000 | $0.00 | 490,000.0000 | 5,512,332 | 9999.99% | 8.89% |
| Nov. 4, 2024 | Elsbree David B | Not found | A | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 5,512,332 | 9999.99% | 0.45% |
| Nov. 4, 2024 | Sprague John M | CFO | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 5,512,332 | 9999.99% | 3.27% |
| Nov. 4, 2024 | Sprague John M | CFO | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 5,512,332 | 9999.99% | 3.27% |
| Sept. 13, 2024 | Elsbree David B | Not found | S | Common Stock | 55 | $2.42 | 25.0000 | 5,512,332 | 68.75% | 0.00% |
| May 9, 2024 | CR Group L.P. | Not found | C | Common Stock | 1716048 | $0.00 | 4,595,977.0000 | 5,512,332 | 59.59% | 31.13% |
| May 9, 2024 | CR Group L.P. | Not found | C | Common Stock | 108752 | $0.00 | 4,704,729.0000 | 5,512,332 | 2.37% | 1.97% |
| May 9, 2024 | CR Group L.P. | Not found | C | Series A Preferred Stock | 17160 | $0.00 | 0.0000 | 5,512,332 | 100.00% | 0.31% |
| May 9, 2024 | CR Group L.P. | Not found | C | Series B Preferred Stock | 10875 | $0.00 | 0.0000 | 5,512,332 | 100.00% | 0.20% |
| May 3, 2024 | CR Group L.P. | Not found | A | Common Stock | 648139 | $0.00 | 8,853,173.0000 | 5,512,332 | 7.90% | 11.76% |
| May 3, 2024 | CR Group L.P. | Not found | A | Common Stock | 403608 | $0.00 | 8,853,173.0000 | 5,512,332 | 4.78% | 7.32% |
| May 3, 2024 | CR Group L.P. | Not found | A | Common Stock | 129629 | $0.00 | 8,853,173.0000 | 5,512,332 | 1.49% | 2.35% |
| May 3, 2024 | CR Group L.P. | Not found | A | Common Stock | 1565445 | $0.00 | 8,853,173.0000 | 5,512,332 | 21.48% | 28.40% |
| May 3, 2024 | CR Group L.P. | Not found | A | Common Stock | 2001514 | $0.00 | 8,853,173.0000 | 5,512,332 | 29.21% | 36.31% |
| April 12, 2024 | CR Group L.P. | Not found | A | Common Stock | 682036 | $0.00 | 4,104,838.0000 | 5,512,332 | 19.93% | 12.37% |
| April 12, 2024 | CR Group L.P. | Not found | A | Common Stock | 424716 | $0.00 | 4,104,838.0000 | 5,512,332 | 11.54% | 7.70% |
| April 12, 2024 | CR Group L.P. | Not found | A | Common Stock | 136409 | $0.00 | 4,104,838.0000 | 5,512,332 | 3.44% | 2.47% |
| April 12, 2024 | CR Group L.P. | Not found | A | Common Stock | 1647315 | $0.00 | 4,104,838.0000 | 5,512,332 | 67.03% | 29.88% |
| April 12, 2024 | CR Group L.P. | Not found | A | Common Stock | 390142 | $0.00 | 4,104,838.0000 | 5,512,332 | 10.50% | 7.08% |
| April 12, 2024 | CR Group L.P. | Not found | A | Series A Convertible Preferred Stock | 17160 | $0.00 | 28,035.7300 | 5,512,332 | 157.79% | 0.31% |
| Feb. 24, 2024 | Sperzel John J III | See Remarks | M | Common Stock | 67 | $0.00 | 400.0000 | 0 | 20.12% | 0.00% |
| Feb. 24, 2024 | Sperzel John J III | See Remarks | M | Restricted Stock Units | 67 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2024 | Sprague John M | Chief Financial Officer | M | Common Stock | 29 | $0.00 | 141.0000 | 0 | 25.89% | 0.00% |
| Feb. 24, 2024 | Sprague John M | Chief Financial Officer | M | Restricted Stock Units | 29 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2024 | Gibbs Michael Terrence | General Counsel | M | Common Stock | 29 | $0.00 | 135.0000 | 0 | 27.36% | 0.00% |
| Feb. 24, 2024 | Gibbs Michael Terrence | General Counsel | M | Restricted Stock Units | 29 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 20, 2024 | Gibbs Michael Terrence | General Counsel | M | Common Stock | 40 | $0.00 | 106.0000 | 0 | 60.61% | 0.00% |
| Feb. 20, 2024 | Gibbs Michael Terrence | General Counsel | M | Restricted Stock Units | 40 | $0.00 | 40.0000 | 0 | 50.00% | 0.00% |
| Feb. 20, 2024 | Sprague John M | Chief Financial Officer | M | Common Stock | 40 | $0.00 | 112.0000 | 0 | 55.56% | 0.00% |
| Feb. 20, 2024 | Sprague John M | Chief Financial Officer | A | Restricted Stock Units | 40 | $0.00 | 40.0000 | 0 | 9999.99% | 0.00% |
| Feb. 20, 2024 | Sperzel John J III | See Remarks | M | Common Stock | 160 | $0.00 | 333.0000 | 0 | 92.49% | 0.00% |
| Feb. 20, 2024 | Sperzel John J III | See Remarks | M | Restricted Stock Units | 160 | $0.00 | 160.0000 | 0 | 50.00% | 0.00% |
| Feb. 20, 2024 | Giffin Brett A. | Chief Commercial Officer | M | Common Stock | 13 | $0.00 | 77.0000 | 0 | 20.31% | 0.00% |
| Feb. 20, 2024 | Giffin Brett A. | Chief Commercial Officer | A | Restricted Stock Units | 13 | $0.00 | 13.0000 | 0 | 9999.99% | 0.00% |
| Feb. 14, 2024 | CR Group L.P. | Not found | C | Common Stock | 335947 | $0.00 | 824,220.0000 | 0 | 68.80% | 0.00% |
| Feb. 14, 2024 | CR Group L.P. | Not found | C | Common Stock | 488273 | $0.00 | 824,220.0000 | 0 | 145.34% | 0.00% |
| Feb. 14, 2024 | CR Group L.P. | Not found | C | Series B Preferred Stock | 33595 | $0.00 | 10,875.2500 | 0 | 75.54% | 0.00% |
| Feb. 14, 2024 | CR Group L.P. | Not found | C | Series B Preferred Stock | 48827 | $0.00 | 10,875.2500 | 0 | 81.78% | 0.00% |
| Jan. 1, 2024 | Toft Robin | Not found | A | Restricted Stock Units | 6369 | $0.00 | 6,369.0000 | 0 | 9999.99% | 0.00% |